Related Experiment Video
Updated: Jun 17, 2026
08:23
Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
Novel therapies in sickle cell disease
1Division of Hematology/Oncology, University of North Carolina, Chapel Hill, NC 27599-7305, USA. kataga@med.unc.edu
Hematology. American Society of Hematology. Education Program
|December 17, 2009
Summary
Novel treatments for sickle cell disease (SCD) are advancing, targeting complications by increasing fetal hemoglobin and improving red blood cell function. Combination therapies may offer comprehensive management for this complex genetic blood disorder.
Area of Science:
- Hematology
- Pharmacology
- Genetics
Background:
- Sickle cell disease (SCD) pathophysiology is better understood, yet effective treatments for complications remain limited.
- Current therapeutic options for SCD are insufficient to address the multifaceted nature of the disease and its sequelae.
Purpose of the Study:
- To review promising novel therapeutic agents currently in clinical development for sickle cell disease.
- To discuss the potential of combination therapies for managing complex SCD pathophysiology and its complications.
Main Methods:
- Literature review of recent advancements in drug development for sickle cell disease.
- Analysis of novel agents targeting various aspects of SCD pathophysiology, including fetal hemoglobin induction, red blood cell hydration, nitric oxide availability, and anti-inflammatory effects.
Main Results:
- Significant progress has been made in developing novel drugs for SCD.
- These agents exhibit diverse mechanisms of action, including increasing fetal hemoglobin, improving red blood cell hydration, enhancing nitric oxide bioavailability, and exerting anti-inflammatory effects.
- Multiple agents are in various stages of clinical trials.
Conclusions:
- Novel therapeutic agents show promise for the prevention and treatment of SCD complications.
- Given the complex nature of SCD, combination therapy with agents possessing different mechanisms of action may be beneficial for patients.
- Further clinical development is warranted to establish the efficacy and safety of these novel SCD treatments.
Related Concept Videos
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.